Newsroom
-
June 14 , 2021
A new model of Alzheimer's progression
- Alzheimer's disease is the most common form of dementia and is characterized by neurodegeneration in regions of the brain involved in memory and learning. Amyloid beta and tau are two toxic proteins that build up in disease and cause eventual neuronal death, but little is known about how other cells in the brain react during disease progression.
Read more -
June 14 , 2021
An omega-3 that's poison for tumors
- So-called "good fatty acids" are essential for human health. Among the Omega-3 fatty acids, DHA, or docosahexaenoic acid, is crucial to brain function, vision and the regulation of inflammatory phenomena.
Read more -
June 14 , 2021
New gene therapy uses Tylenol to combat genetic diseases
- Researchers have developed a new approach to gene therapy that leans on the common pain reliever acetaminophen to force a variety of genetic diseases into remission.
Read more -
June 14 , 2021
Study finds dosing strategy may affect immunotherapy outcomes
- Overweight cancer patients receiving immunotherapy treatments live more than twice as long as lighter patients, but only when dosing is weight-based, according to a study by cancer researchers at UT Southwestern Medical Center.
Read more -
June 14 , 2021
Toward the first drug to treat a rare, lethal liver cancer
- Sanford M. Simon and his group understood that patients dying of fibrolamellar could not afford to wait.The team ultimately discovered a few classes of therapeutics that destroy fibrolamellar tumor cells growing in mice. Their findings are published in Cancer Discovery.
Read more